Second-generation antihistamine (H1 antagonist)
Pregnancy: Generally considered safe. Loratadine often preferred (more data).
Cetirizine
Brand names: Zirtek, Benadryl Allergy
Adult dose
Dose: 10 mg once daily
Route: Oral
Frequency: Once daily (evening if sedating; morning if non-sedating in that patient)
Max: 10 mg/day
Allergic rhinitis, urticaria, eczema: 10 mg once daily. Less sedating than chlorphenamine. Available OTC. Evening dosing preferred for overnight effect on nasal symptoms.
Paediatric dose
Route: Oral
Frequency: Once daily
Max: 10 mg/day
Concentration: 5 mg/ml
6 months–1 year: 2.5 mg once daily (limited data). 1–2 years: 2.5 mg twice daily. 2–6 years: 2.5 mg twice daily (or 5 mg once daily). 6–11 years: 5 mg once daily or 5 mg twice daily. ≥12 years: 10 mg once daily.
Dose adjustments
Renal
Reduce dose if eGFR <30: 5 mg once daily.
Hepatic
No dose adjustment required.
Clinical pearls
- Second-generation antihistamine — much less sedating than chlorphenamine
- Non-sedating antihistamines preferred for daytime use and work/driving
- For urticaria: up to 4× standard dose licenced under specialist guidance (BSACI)
- Does not cross blood-brain barrier as readily — safer for elderly (lower fall risk than first-gen)
- Loratadine and fexofenadine are truly non-sedating alternatives
Contraindications
- Hypersensitivity to cetirizine or hydroxyzine
Side effects
- Sedation (less common than first-generation; may still occur in some individuals)
- Headache
- Dry mouth
- Fatigue
- GI upset
Interactions
- CNS depressants — additive sedation
- Ritonavir — may increase cetirizine levels
Monitoring
- Symptom response
- Sedation level
Reference: BNFc; BNF; BSACI Urticaria Guidelines; ARIA Guidelines; BNFc. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020